• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number UNK TRIFECTA GT VALVE
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Angina (1710); Endocarditis (1834)
Event Date 01/01/2015
Event Type  Injury  
Manufacturer Narrative
B3 - date of event is estimated.D4 - the udi number is not known as the part and lot numbers were not provided summarized patient outcomes/complications of patient prothesis miss-match on long term survival and quality of life were reported in a research article.Some of the complications reported were endocarditis, redo surgery, and angina.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Event Description
The article, "clinical impact of patient-prosthesis mismatch after aortic valve replacement with a mechanical or biological prosthesis", was reviewed.The article presented a prospective, single center study to investigate the impact of patient-prosthesis mismatch (ppm) on long-term survival and quality of life after mechanical and biological aortic valve replacement.Devices included in this study were sjm masters, sjm regent, medtronic ats open pivot, cyrolife on-x, livanova carbomedics, medtronic hancock ii, abbott epic, abbott trifecta gt, livanova crown prt, livanova solosmart, and livanova perceval s.The article concluded mismatch is common after biological valve implantation and statistically significantly affects long-term survival and quality of life.If the risk of ppm after implantation of a biological prosthesis is suspected, adopting strategies to avoid ppm at the time of surgery is warranted.[the primary and corresponding author was (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA¿ GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18150993
MDR Text Key328306128
Report Number2135147-2023-05059
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 11/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK TRIFECTA GT VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
-
-